Edition:
United States

Oculus Innovative Sciences Inc (OCLS.OQ)

OCLS.OQ on NASDAQ Stock Exchange Capital Market

4.86USD
2 Dec 2016
Change (% chg)

$-0.03 (-0.61%)
Prev Close
$4.89
Open
$4.93
Day's High
$4.93
Day's Low
$4.86
Volume
2,249
Avg. Vol
12,237
52-wk High
$7.10
52-wk Low
$3.61

Summary

Name Age Since Current Position

James Schutz

52 2013 President, Chief Executive Officer, Director

Robert Northey

58 2014 Executive Vice President - Research and Development

Bruce Thornton

51 2008 Executive Vice President - International Operations and Sales

Robert Miller

72 2013 Chief Financial Officer, Chief Operating Officer, Secretary

Jerry McLaughlin

68 2014 Lead Independent Director

Sharon Barbari

61 2014 Independent Director

Jay Birnbaum

70 2007 Independent Director

Russell Harrison

70 2014 Independent Director

Dan McFadden

IR Contact Officer

Biographies

Name Description

James Schutz

Mr. James Schutz is President, Chief Executive Officer, Director of Oculus Innovative Sciences, Inc. Mr. Schutz has most recently held the position of our Chief Operating Officer and General Counsel, and has served in various other capacities as an executive officer of our Company since August 2003. He has also served as a director of our Company since May 2004. From August 2001 to August 2003, Mr. Schutz served as General Counsel at Jomed (formerly EndoSonic Corp.), an international medical device company. From 1999 to July 2001, Mr. Schutz served as in-house counsel at Urban Media Communications Corporation, an Internet/telecom company based in Palo Alto, California. Mr. Schutz received a B.A. in economics from the University of California, San Diego and a J.D. from the University of San Francisco School of Law.

Robert Northey

Mr. Robert Northey, Ph.D. is Executive Vice President - Research and Development of Oculus Innovative Sciences, Inc. since July 2005. Dr. Northey served as a consultant to the company from May 2001 to June 2005. From August 1998 until June 2005, he was an assistant professor in the paper science and engineering department at the University of Washington. Dr. Northey received a B.S. in wood and fiber science and a Ph.D. in wood chemistry, each from the University of Washington.

Bruce Thornton

Mr. Bruce Thornton is Executive Vice President - International Operations and Sales of Oculus Innovative Sciences, Inc. He was Vice President of International Operations and Sales of Oculus Innovative Sciences, Inc. since June 2005. Mr. Thornton served as General Manager for U.S. Operations from March 2004 to July 2005. He served as Vice President of Operations for Jomed (formerly EndoSonic Corp.) from January 1999 to September 2003, and as Vice President of Manufacturing for Volcano Therapeutics, an medical device company, following its acquisition of Jomed, until March 2004. Mr. Thornton received a B.S. in Aeronautical Science from Embry-Riddle Aeronautical University and an M.B.A. from National University.

Robert Miller

Mr. Robert Miller is Chief Financial Officer, Chief Operating Officer, Secretary of Oculus Innovative Sciences, Inc. He was a consultant to us from March 2003 to May 2004. Mr. Miller has served as a director of Scanis, Inc. since 1998 and served as the acting Chief Financial Officer of Scanis from 1998 to June 2006. He was a Chief Financial Officer consultant to Evit Labs from June 2003 to December 2004, Wildlife International Network from October 2002 to December 2005, Endoscopic Technologies from November 2002 to March 2004, Biolog from January 2000 to December 2002 and Webware from August 2000 to August 2002. Prior to this, Mr. Miller was the Chief Financial Officer for GAF Corporation, Penwest Ltd. and Bugle Boy, and the Treasurer of Mead Corporation. He received a B.A. in economics from Stanford University and an M.B.A. in finance from Columbia University.

Jerry McLaughlin

Mr. Jerry G. McLaughlin is Lead Independent Director of Oculus Innovative Sciences, Inc. Mr. McLaughlin has served as Interim Chief Executive Officer of Applied BioCode, Inc. since November 2011. He also founded in April 2011 and currently serves as President and Chief Executive Officer of DataStream Medical Imaging Systems, Inc., a start-up to develop diagnostic imaging software applications that work in conjunction with existing digital radiology platforms. He previously served as President of DataFlow Information Systems, from July 2007 to December 2011, and President and Chief Executive Officer of CompuMed, Inc. from May 2002 to June 2007.

Sharon Barbari

Ms. Sharon A. Barbari is an Independent Director of Oculus Innovative Sciences, Inc. Ms. Barbari has served as Executive Vice President - Finance and Chief Financial Officer, of Cytokinetics Inc. since July 2009. She served as Senior Vice President of Finance and Chief Financial Officer from September 2004 through June 2009. From September 2002 to August 2004, Ms. Barbari served as Chief Financial Officer and Senior Vice President of Finance and Administration of InterMune, Inc., a biopharmaceutical company. From January 1998 to June 2002, she served at Gilead Sciences, Inc., a biopharmaceutical company, and held several positions of increasing responsibility including most recently as its Vice President and Chief Financial Officer. From 1996 to 1998, Ms. Barbari served as Vice President, Strategic Planning at Foote, Cone & Belding Healthcare in San Francisco, an international advertising and marketing firm. From 1972 to 1995, she was employed by Syntex Corporation where she held various management positions in corporate finance, financial planning, marketing and commercial planning. Ms. Barbari received a B.S. in accounting from San Jose State University.

Jay Birnbaum

Dr. Jay E. Birnbaum is Independent Director of Oculus Innovative Sciences, Inc. Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies in his area of expertise. He previously served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals Corporation, where he had responsibility for strategic planning and development of the company’s dermatology portfolio. Dr. Birnbaum is also a co-founder and former Chief Medical Officer of Kythera Biopharmaceuticals, and has served on the board of directors of Excaliard Pharmaceuticals (a company recently acquired by Pfizer) and on the scientific advisory boards of several companies. Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.

Russell Harrison

Mr. Russell Harrison is an Independent Director of Oculus Innovative Sciences, Inc. Mr. Harrison is the founding principal of The Leadership Group, LLC, a firm specializing in strategic change and executive coaching for U.S. and international companies, a position he has held since January 2012. From 2006 to 2012, he was employed by CoolSystems, Inc. d/b/a Game Ready, Inc. and was appointed its President and Chief Executive Officer in 2007. Mr. Harrison has also served in the role of chief executive officer for a number of publicly traded and private technology businesses in both the information technology and medical device technology sectors. His career includes senior executive experience spanning global markets, building new companies and improving performance in under-achieving businesses. From 1991 to 1993, Mr. Harrison served as the first Chief Information Officer for McKesson Corporation, responsible for all computer technology-related activities. From 1995 to 1997, he served as Chief Information Officer at SITA Telecommunications Holdings in Paris, where he led a team responsible for technology spanning more than 200 countries and territories. Prior to that time, Mr. Harrison was employed in various positions at Bank of America, both domestically and internationally, and at Electronic Data Systems, Inc. He was also the founding president of AMR Information Systems, an American Airlines information technology subsidiary. Mr. Harrison received an MBA with Honors from Saint Mary’s College of California, and has served as President of the Board of Regents, and as Chairman of the Board of Trustees of Saint Mary’s. He earned his bachelor’s degree in economics from the University of Southern California, and also served as a captain in the United States Marine Corps.

Dan McFadden

Basic Compensation